NFG
FOLD

Next Financial Group’s Amicus Therapeutics FOLD Stock Holding History

Next Financial Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,625
Closed -$26K – 2214
2019
Q4 		$26K Hold
2,625
– – ﹤0.01% 1428
2019
Q3 		$21K Hold
2,625
– – ﹤0.01% 1429
2019
Q2 		$33K Hold
2,625
– – ﹤0.01% 1298
2019
Q1 		$36K Hold
2,625
– – 0.01% 810
2018
Q4 		$25K Hold
2,625
– – 0.01% 1022
2018
Q3 		$32K Buy
+2,625
New +$36.7K 0.01% 644
2017
Q4 		– Sell
-2,625
Closed -$38K – 651
2017
Q3 		$38K Sell
2,625
-1,500
-36% -$19.8K 0.01% 778
2017
Q2 		$42K Hold
4,125
– – 0.01% 833
2017
Q1 		$32K Buy
+4,125
New +$26.1K 0.01% 875

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Next Financial Group's FOLD Position: Q1 2020 in Review

Next Financial Group sold out of Amicus Therapeutics (FOLD) in Q1 2020, closing a stake of 2,625 shares — an estimated $26K sold.

Next Financial Group first reported a position in FOLD in Q1 2017 and held it in 9 quarters. The position peaked at $42K in Q2 2017. 202 funds tracked by Wall St. Rank hold FOLD as of Q1 2020.

  • Next Financial Group reported no remaining Amicus Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Next Financial Group sold 2,625 Amicus Therapeutics shares in Q1 2020, an estimated $26K.
  • Next Financial Group first reported a position in Amicus Therapeutics in Q1 2017 and held it in 9 quarters.
  • Next Financial Group's Amicus Therapeutics position peaked at $42K in Q2 2017.
  • 202 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2020.

Based on Next Financial Group's 13F filing for Q1 2020, filed 27 Apr 2020.